Stage IV colon cancer patients without DENND2D expression benefit more from neoadjuvant chemotherapy

Por Wen-juan Ma, Yukun Chen, Jian-hong Peng, Chaoming Tang, Ling Zhang, Min Liu, Shanshan Hu, Haineng Xu, Hua Tan, Yangkui Gu, Zhi-zhong Pan, Gong Chen, Zhong-guo Zhou, Rong-xin Zhang
Publicado em 2022-05-01